Company · CIK 0002131524 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Braveheart Bio, Inc. · BRVE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 PForm 4 → | Aug 11, 5:53 pm EDT | AH Bio Fund IV, L.P. +310% Owner | 1,100,000 | $18.00 | $19,800,000 | 10,232,420 | +12.0% | |
| Aug 7, 2026 CForm 4 → | Aug 11, 5:53 pm EDT | AH Bio Fund IV, L.P. +310% Owner | 9,132,420 | — | — | 9,132,420 | — | |
| Aug 7, 2026 PForm 4 → | Aug 11, 5:31 pm EDT | Erez ChimovitsDirector, 10% Owner | 1,940,000 | $18.00 | $34,920,000 | 273,333 | — | |
| Aug 7, 2026 CForm 4 → | Aug 11, 5:31 pm EDT | Erez ChimovitsDirector, 10% Owner | 9,132,420 | — | — | 10,235,159 | — | |
| Aug 7, 2026 PForm 4 → | Aug 11, 5:27 pm EDT | ORBIMED ADVISORS LLC +2Director, 10% Owner | 1,940,000 | $18.00 | $34,920,000 | 273,333 | — | |
| Aug 7, 2026 CForm 4 → | Aug 11, 5:27 pm EDT | ORBIMED ADVISORS LLC +2Director, 10% Owner | 9,132,420 | — | — | 10,235,159 | — | |
| Aug 7, 2026 CForm 4 → | Aug 10, 10:03 am EDT | Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% Owner | 7,420,091 | — | — | 7,420,091 | — | |
| Aug 7, 2026 PForm 4 → | Aug 7, 5:25 pm EDT | Forbion Growth Opportunities Fund III Cooperatief U.A. +310% Owner | 3,600,000 | $18.00 | $64,800,000 | 10,185,478 | +54.7% | |
| Aug 7, 2026 CForm 4 → | Aug 7, 5:25 pm EDT | Forbion Growth Opportunities Fund III Cooperatief U.A. +310% Owner | 17,123,287 | — | — | 8,505,478 | — | |
| Aug 7, 2026 PForm 4 → | Aug 7, 4:41 pm EDT | James Paul RickeyChief Financial Officer | 27,777 | $18.00 | $499,986 | 520,927 | +5.63% | |
| Aug 7, 2026 PForm 4 → | Aug 7, 4:31 pm EDT | Christopher ViehbacherDirector | 83,333 | $18.00 | $1,499,994 | 609,519 | +15.8% | |
| Aug 7, 2026 PForm 4 → | Aug 7, 4:31 pm EDT | David I MalekDirector | 4,166 | $18.00 | $74,988 | 533,845 | +0.79% | |
| Aug 7, 2026 PForm 4 → | Aug 7, 4:30 pm EDT | Michele A. AndersonChief Development Officer | 1,111 | $18.00 | $19,998 | 332,161 | +0.34% | |
| Aug 7, 2026 PForm 4 → | Aug 7, 4:30 pm EDT | Travis MurdochCEO and President, Director | 83,333 | $18.00 | $1,499,994 | 2,940,670 | +2.92% | |
| Aug 7, 2026 PForm 4 → | Aug 7, 4:30 pm EDT | David Charles LubnerDirector | 55,555 | $18.00 | $999,990 | 55,555 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 CForm 4 → | Aug 11, 5:53 pm EDT | AH Bio Fund IV, L.P. +310% Owner | 40,000,000 | — | — | 0 | — | |
| Aug 7, 2026 CForm 4 → | Aug 11, 5:31 pm EDT | Erez ChimovitsDirector, 10% Owner | 40,000,000 | — | — | 0 | — | |
| Aug 7, 2026 CForm 4 → | Aug 11, 5:27 pm EDT | ORBIMED ADVISORS LLC +2Director, 10% Owner | 40,000,000 | — | — | 0 | — | |
| Aug 7, 2026 CForm 4 → | Aug 10, 10:03 am EDT | Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% Owner | 32,500,000 | — | — | 0 | — | |
| Aug 7, 2026 CForm 4 → | Aug 7, 5:25 pm EDT | Forbion Growth Opportunities Fund III Cooperatief U.A. +310% Owner | 75,000,000 | — | — | 0 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 4:41 pm EDT | James Paul RickeyChief Financial Officer | 300,000 | — | — | 300,000 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 4:41 pm EDT | Tim LohoffDirector | 30,000 | — | — | 30,000 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 4:31 pm EDT | Erez ChimovitsDirector, 10% Owner | 30,000 | — | — | 30,000 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 4:31 pm EDT | Christopher ViehbacherDirector | 30,000 | — | — | 30,000 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 4:31 pm EDT | David I MalekDirector | 30,000 | — | — | 30,000 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 4:30 pm EDT | Michele A. AndersonChief Development Officer | 300,000 | — | — | 300,000 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 4:30 pm EDT | Travis MurdochCEO and President, Director | 550,000 | — | — | 550,000 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 4:30 pm EDT | Jasper BosDirector | 30,000 | — | — | 30,000 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 4:30 pm EDT | David Charles LubnerDirector | 60,000 | — | — | 60,000 | — |